Affimed

Germany
Heidelberg, Baden-Wurttemberg, Germany
+49 (0)6221-6743-60 ★

Company profile

Affimed company profile

At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim to overcome the limitations and challenges faced by current immuno-oncology (I-O) therapies.

Business identity

Contact email
[email protected]
Phone number
+49 (0)6221-6743-60
Operating status
Active
Company type
For Profit
Employee range
00051-00100 employees
Revenue range
$1K+
Founded
2000-01-01

Headquarters

Headquarters
Heidelberg, Baden-Wurttemberg, Germany
Postal code
69120
Country code
DE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
14
Total equity funding
$504.9M
Last funding
Post Ipo Equity / $90M / 2022-04-13
Last equity funding
Post Ipo Equity / $90M
Investors
13
Lead investors
8
Founders
1
Articles
102
Exited on
2014-09-12

Founders and investors

Founders

Melvyn Little

Lead investors

Aeris CapitalBioMedPartnersEQT Life SciencesGerman Federal Ministry of Education and ResearchOrbiMedPerceptive AdvisorsRocheSilicon Valley Bank

Investors

EQT Life SciencesNew Enterprise AssociatesNovo HoldingsNovo NordiskRoche

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.